Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) $ in Thousands |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Accounts Receivable, Allowance for Credit Loss | $ 1,000 | $ 700 | $ 1,000 |
| Advertising Expense | 23,400 | 19,900 | |
| Operating Expenses | 160,103 | 147,944 | |
| Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) | 0 | 4,000 | |
| Trademarks [Member] | |||
| Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) | $ 4,000 | 0 | 4,000 |
| Shipping and Handling [Member] | |||
| Operating Expenses | $ 30,100 | $ 27,000 | |
| Minimum [Member] | |||
| Revenue From Contract /with Customer, Payment Term (Day) | 30 days | ||
| Maximum [Member] | |||
| Revenue From Contract /with Customer, Payment Term (Day) | 60 years | ||
| Customer Concentration Risk [Member] | Accounts Receivable [Member] | |||
| Number of Major Customers | 1 | 0 | |
| Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member] | |||
| Concentration Risk, Percentage | 15.00% | ||
| X | ||||||||||
- Definition Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. No definition available.
|
| X | ||||||||||
- Definition Period of payment for revenue from contract with customer. No definition available.
|
| X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of allowance for credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|